Currently out of the existing stock ratings of Matthew Sykes, 54 are a HOLD (35.53%), 78 are a BUY (51.32%), 20 are a SELL (13.16%).

Matthew Sykes

Work Performance Price Targets & Ratings Chart

Analyst Matthew Sykes works at GOLDMAN SACHS with a stock forecast success ratio of 46.77% fulfilled within 70.32 days on average.

Matthew Sykes’s has documented 284 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on NEO, NeoGenomics at 22-Feb-2024.

Wall Street Analyst Matthew Sykes

Analyst best performing recommendations are on ZY (ZYMERGEN).
The best stock recommendation documented was for ZY (ZYMERGEN) at 8/4/2021. The price target of $12 was fulfilled within 1 day with a profit of $3.75 (45.45%) receiving and performance score of 454.55.

Average potential price target upside

DHR Danaher MRVI Maravai Lifesciences Holdings  NAUT Nautilus Biotechnology NTRA Natera NVTA Invitae Corp PKI PerkinElmer TMO Thermo Fisher Scientific TXG 10X Genomics WAT Waters ZY Zymergen OMIC Singular Genomics Systems GH Guardant Health MYGN Myriad Genetics NEO NeoGenomics QTRX Quanterix Corp CTKB Cytek Biosciences HLTH Cue Health OLK Olink Holding AB ADR TX Ternium SA ADR CDNA Caredx MTD Mettler-Toledo International SMFR Sema4 Holdings Corp AVTR Avantor EXAS EXACT Sciences BRKR Bruker LMDX LumiraDx Ltd TWST Twist Bioscience Corp A Agilent Technologies DNA Ginkgo Bioworks Holdings QGEN Qiagen NV VCYT Veracyte

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

290

$36.16 (14.25%)

260

23 days ago

2/7 (28.57%)

$44.87 (18.30%)

182

Buy

270

$16.16 (6.37%)

240

24 days ago

3/5 (60%)

$30.09 (12.54%)

138

Buy

240

$-13.84 (-5.45%)

215

1 months ago

8/16 (50%)

$11.39 (4.98%)

127

Hold

2 months 11 days ago

6/7 (85.71%)

$56.59 (22.31%)

264

Hold

2 months 11 days ago

2/3 (66.67%)

$-13.49 (-19.70%)

550

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Matthew Sykes is most bullish on?

Potential upside of $42.47 has been obtained for EXAS (EXACT SCIENCES)

Which stock is Matthew Sykes is most reserved on?

Potential downside of -$179.79 has been obtained for MTD (METTLER-TOLEDO INTERNATIONAL)

What Year was the first public recommendation made by Matthew Sykes?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?